[HTML][HTML] Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study
M Bartoletti, L Marconi, L Scudeller, L Pancaldi… - Clinical Microbiology …, 2021 - Elsevier
Objective To assess the efficacy of corticosteroids in patients with coronavirus disease 2019
(COVID-19). Methods A multicentre observational study was performed from 22 February …
(COVID-19). Methods A multicentre observational study was performed from 22 February …
Impact of corticosteroids in hospitalised COVID-19 patients
KS Ho, B Narasimhan, L Difabrizio… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …
[HTML][HTML] Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
Z Liu, X Li, G Fan, F Zhou, Y Wang, L Huang… - Clinical Microbiology …, 2021 - Elsevier
Objectives Use of corticosteroids is common in the treatment of coronavirus disease 2019,
but clinical effectiveness is controversial. We aimed to investigate the association of …
but clinical effectiveness is controversial. We aimed to investigate the association of …
Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: a multicenter, single-blind, randomized …
X Tang, YM Feng, JX Ni, JY Zhang, LM Liu, K Hu… - Respiration, 2021 - karger.com
Background: There is still no clinical evidence available to support or to oppose
corticosteroid treatment for coronavirus disease 2019 (COVID-19) pneumonia. Objective: To …
corticosteroid treatment for coronavirus disease 2019 (COVID-19) pneumonia. Objective: To …
[HTML][HTML] Efficacy evaluation of early, low-dose, short-term corticosteroids in adults hospitalized with non-severe COVID-19 pneumonia: a retrospective cohort study
Q Li, W Li, Y Jin, W Xu, C Huang, L Li, Y Huang… - Infectious diseases and …, 2020 - Springer
Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-
19 pneumonia. Methods A retrospective study based on propensity score matching was …
19 pneumonia. Methods A retrospective study based on propensity score matching was …
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes
FE Chaharom, L Pourafkari, AAE Chaharom… - Pulmonary …, 2022 - Elsevier
Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …
[HTML][HTML] The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis
J Wang, W Yang, P Chen, J Guo, R Liu, P Wen, K Li… - PloS one, 2021 - journals.plos.org
Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …
The impact of corticosteroids on secondary infection and mortality in critically ill COVID-19 patients
Background: Corticosteroids are part of the treatment guidelines for COVID-19 and have
been shown to improve mortality. However, the impact corticosteroids have on the …
been shown to improve mortality. However, the impact corticosteroids have on the …
Early short-course corticosteroids in hospitalized patients with COVID-19
R Fadel, AR Morrison, A Vahia, ZR Smith… - Clinical Infectious …, 2020 - academic.oup.com
Background There is no proven antiviral or immunomodulatory therapy for coronavirus
disease 2019 (COVID-19). The disease progression associated with the proinflammatory …
disease 2019 (COVID-19). The disease progression associated with the proinflammatory …
[HTML][HTML] High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
E Monreal, S Sainz de la Maza… - European Journal of …, 2021 - Springer
Despite the increasing evidence of the benefit of corticosteroids for the treatment of
moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available …
moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available …